SpaceX launched the CRS-35 cargo mission to the International Space Station, carrying bioengineered human brain and cardiovascular tissue models designed to study how spaceflight impacts human health and accelerates aging. Researchers from the Icahn School of Medicine at Mount Sinai, NASA, and Space Tango orchestrated the payload to test how microgravity and radiation alter cellular structures.
SpaceX CRS-35 Launch Delivers Bioengineered Tissues to Orbit
The SpaceX CRS-35 cargo resupply mission lifted off from Cape Canaveral Space Force Station in Florida, transporting miniature organ systems to the orbiting laboratory. The payload was launched on Tuesday morning and is expected to arrive at the International Space Station to expose biological models to the increased radiation and microgravity environments encountered on long-duration spaceflights.
The mission builds upon prior work conducted by Mount Sinai’s Cardiovascular Research Institute, which sent individual heart cells to the station in 2023 to verify that cardiac cells could survive in weightlessness. The current payload expands that research by delivering complex, multi-cellular tissue models housed inside automated, miniaturized laboratory units known as CubeLabs, developed by aerospace company Space Tango.
Mount Sinai Researchers Deploy miBrain and Cardiovascular Chips
The scientific payload features two primary biomedical projects focusing on neurological and cardiac function. The first project utilizes miBrain, a peppercorn-sized model derived from patient-derived stem cells that contains neurons, astrocytes, immune cells, and vasculature. Joel W. Blanchard, Associate Professor of Stem Cell Biology and Regenerative Medicine and Neuroscience at Mount Sinai, stated that the research could establish miBrain as a tool for assessing neurological risk before and during spaceflight.
What if the next breakthrough for Alzheimer's arrives from orbit? 🧠This morning, SpaceX launched CRS-35 from Cape Canaveral carrying something extraordinary: peppercorn-sized mini brains, miniature hearts, and hardware to make artificial retinas — all headed to the ISS.Mount… pic.twitter.com/XnaquEyTpp
The second project targets cardiovascular health through a microfluidic device called the µCVchip, engineered by Kevin D. Costa and David Sachs. Each chip holds up to 16 miniature cardiovascular organoids that undergo daily electrical pacing, pressure testing, imaging, and fluid sampling aboard the station. Kevin D. Costa noted that six months in space is equivalent to about 10 to 20 years of aging on Earth, providing a model for studying degenerative processes.
Translating Orbital Cellular Data to Earth-Bound Healthcare
Researchers intend for the physiological data gathered in orbit to inform both astronaut preparation and terrestrial medicine. Sarah E. Millar, Dean for Academic and Scientific Affairs at Mount Sinai, stated that the results will help refine how space crews prepare for missions while potentially improving care for aging populations on Earth. By examining how extreme environments trigger accelerated aging, heart strain, and neurological loss, scientists aim to identify biomarkers for conditions such as Parkinson’s and Alzheimer’s disease.
Lisa Carnell, director of the biological and physical sciences division at NASA, told ABC News that these spaceflight experiments serve as a starting point for future research beyond low Earth orbit, including to the moon and beyond.
Frequently Asked Questions About Space Organoid Research
How do miniature organoids simulate human aging in space?
The combination of microgravity and heightened radiation exposure places severe stress on cellular systems, prompting physical decline similar to terrestrial aging over a compressed timeline. Kevin D. Costa noted that six months in space is equivalent to about 10 to 20 years of aging on Earth, allowing researchers to study cardiovascular and neurological deterioration quickly.
What equipment houses the tissue models aboard the International Space Station?
The biological models travel and operate inside CubeLabs, which are fully automated, miniaturized laboratory systems slightly bigger than a shoebox designed by Space Tango. These units maintain required environmental controls, perform daily electrical pacing, and execute fluid sampling automatically.
How does this space research apply to patients on Earth?
The cellular degradation caused by microgravity mimics terrestrial conditions such as prolonged bed rest or a sedentary lifestyle. Joel W. Blanchard noted that the findings translate back to laboratory studies aimed at helping people with Parkinson’s and Alzheimer’s disease.
Keep reading